Please login to the form below

Not currently logged in
Email:
Password:

Minoryx Therapeutics adds to board of directors

Dr Claude Nicaise joins as an independent board member

Minoryx Therapeutics Dr Claude NicaiseDr Claude Nicaise has joined Barcelona, Spain-based Minoryx Therapeutics as an independent board member.

He brings over 30 years of regulatory strategy expertise to the orphan diseases specialist, and currently also serves as a board member at Sarepta Therapeutics.

Dr Nicaise founded Clinical Regulatory Services, a biotech-focused advisory service, in 2014, having previously served as senior vice president of strategic development and global regulatory affairs at Alexion Pharmaceuticals from 2008.

Prior to this, Dr Nicaise was vice president of development at Bristol-Myers Squibb, having held a series of regulatory and project leadership positions since joining as director of clinical cancer research in 1984.

Khalid Islam, chairman of the board at Minoryx Therapeutics, said: “We are delighted to have Dr Nicaise join us as an independent board member.

“Claude's perspective, based on his distinguished career and leadership roles in R&D organisations, will be very valuable to the board as the company continues its on-going evolution.”

10th February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics